Fig. 1From: Astragaloside IV ameliorates experimental autoimmune myasthenia gravis by regulating CD4 + T cells and altering gut microbiotaA Identification of the drug-target disease-related genes by taking an intersection of AS-IV target genes and MG-related genes. B KEGG pathway enrichment analysis of the target genesBack to article page